MK-677 (25mg) x 60 Tablets

• Composition and format
MK-677 (Ibutamoren) 25 mg × 60 tablets is a solid-matrix small-molecule research formulation supplied as sixty 25 mg compressed units per container. Batch COAs document identity, net content per unit, and formulation details (including excipient profile, if applicable) to support method reproducibility and documentation control.

• Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.

• Intended research use
MK-677 is provided for controlled in-vitro and ex-vivo investigations into ghrelin receptor pathway characterization, assay development, and receptor-ligand interaction profiling. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes.

• Research characteristics and applications
This solid-dose format enables dissolution testing, stability profiling, impurity tracking, and comparative method validation under defined laboratory conditions. Representative applications include matrix-assisted delivery modeling, receptor binding/activation studies, and forced-degradation assessments to inform analytical method suitability. Language avoids functional or outcome claims and adheres to ABM’s safe-phrasing standards.

• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.

Research Use Only (RUO) Statement
• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use